MedPath
HSA Approval

DBL PROMETHAZINE HYDROCHLORIDE INJECTION BP 50 mg/2 ml

SIN02707P

DBL PROMETHAZINE HYDROCHLORIDE INJECTION BP 50 mg/2 ml

DBL PROMETHAZINE HYDROCHLORIDE INJECTION BP 50 mg/2 ml

May 3, 1989

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

R06AD02

promethazine

Manufacturer Information

PFIZER PRIVATE LIMITED

Siegfried Hameln GmbH

Active Ingredients

PROMETHAZINE HCl

50 mg

Promethazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DBL PROMETHAZINE HYDROCHLORIDE INJECTION BP 50 mg/2 ml - HSA Approval | MedPath